tiprankstipranks
PharmaDrug Eyes Global Market with Biosynthetic Cocaine
Company Announcements

PharmaDrug Eyes Global Market with Biosynthetic Cocaine

Pharmadrug (TSE:PHRX) has released an update.

Don't Miss Our Christmas Offers:

PharmaDrug Inc. has announced its subsidiary, SecureDose, has signed a Letter of Intent with a Canadian licensed dealer to manufacture and distribute biosynthetic pharmaceutical grade cocaine, aiming to contribute to harm reduction through safe supply programs. The company is advancing towards a full agreement post technology transfer and commercial-scale process application, with potential global distribution and revenue opportunities.

For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPharmaDrug Completes Strategic Debenture Issuance
TipRanks Canadian Auto-Generated NewsdeskPharmaDrug Debenture Units Issuance Announcement
TipRanks Canadian Auto-Generated NewsdeskPharmaDrug Advances PD-001 for Clinical Trials
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App